KRAS and neoplasm: His tumor harbored KRAS p.G13D (p.Gly13Asp; c.38G > A) and two TP53 (p.Pro278Ser; c.832C > T and p.Gln331*; c.991C > T) mutations, all of which were detected in his baseline plasma (Figure 6D).